1-20 of 64
Andrew Belch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall and Progression Free Survival from the Mcrn-003/Myx.1 Trial: A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma

Christopher P Venner, MD, Richard Leblanc, MDFRCPC, Irwindeep Sandhu, MDFRCPC, Darrell J White, MD, Andrew Belch, MD, Donna E Reece, MD, Christine I Chen, MD, Sean Dolan, MD, Marc Lalancette, MD FRCP, Martha L Louzada, MDMSc, Andrea Kew, MDFRCP(C), Arleigh McCurdy, MD, Tony Reiman, MD, Max Sherry, Gail T. McDonald, Bethany Elaine Monteith, MD, Engin Gul, BS, MBA, Bingshu E. Chen, Annette E. Hay
Journal: Blood
Blood (2019) 134 (Supplement_1): 1871.
https://doi.org/10.1182/blood-2019-122637
Published: 2019
Journal Articles

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

Clinical Trials & Observations
Thierry Facon, Meletios A. Dimopoulos, Angela Dispenzieri, John V. Catalano, Andrew Belch, Michele Cavo, Antonello Pinto, Katja Weisel, Heinz Ludwig, Nizar J. Bahlis, Anne Banos, Mourad Tiab, Michel Delforge, Jamie D. Cavenagh, Catarina Geraldes, Je-Jung Lee, Christine Chen, Albert Oriol, Javier De La Rubia, Darrell White, Daniel Binder, Jin Lu, Kenneth C. Anderson, Philippe Moreau, Michel Attal, Aurore Perrot, Bertrand Arnulf, Lugui Qiu, Murielle Roussel, Eileen Boyle, Salomon Manier, Mohamad Mohty, Herve Avet-Loiseau, Xavier Leleu, Annette Ervin-Haynes, Guang Chen, Vanessa Houck, Lotfi Benboubker, Cyrille Hulin
Journal: Blood
Blood (2018) 131 (3): 301–310.
https://doi.org/10.1182/blood-2017-07-795047
Published: 2018
Includes: Supplemental data
Journal Articles

Detection of Minimal Residual Disease in Autograft Is Prognostic of Survival Following Stem Cell Transplant in Multiple Myeloma

Michael P. Chu, MD, Eva Baigorri, Jitra Kriangkum, PhD, Joanne D. Hewitt, NP, PhD, Andrew Belch, Christopher P. Venner, Irwindeep Sandhu, MDFRCPC, Linda M. Pilarski, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1928.
https://doi.org/10.1182/blood.V130.Suppl_1.1928.1928
Published: 2017
Journal Articles

Safety and Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed and Refractory Multiple Myeloma: Final Results from GEN501 and Sirius

Saad Z Usmani, MD, Hareth Nahi, Brendan M Weiss, MD, Nizar J. Bahlis, MD, Andrew Belch, Henk M Lokhorst, Peter M. Voorhees, MD, Paul G Richardson, MD, Clarissa Uhlar, Jianping Wang, Ming Qi, Sagar Lonial, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3107.
https://doi.org/10.1182/blood.V130.Suppl_1.3107.3107
Published: 2017
Journal Articles

The Survival Impact of Lenalidomide Maintenance Chemotherapy in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplant and Bortezomib-Based Induction: An Analysis of Real World Data

Hannah Cherniawsky, BSc, MD, Irwindeep Sandhu, MDFRCPC, Michael P. Chu, MD, Joanne D. Hewitt, NP, PhD, Ismail Ismail, Andrew Belch, Linda M. Pilarski, PhD, Tatiana Nikitina, PhD, Christopher P. Venner, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3132.
https://doi.org/10.1182/blood.V130.Suppl_1.3132.3132
Published: 2017
Journal Articles

The Evolving Impact on Survival Outcomes in Multiple Myeloma with Greater Access to Novel Treatment Regimens: Experience in a Real-World Cohort

Zack M. Breckenridge, BSc, Victor Jimenez-Zepeda, MD, Nizar J. Bahlis, MD, Paola Neri, MD, Irwindeep Sandhu, MDFRCPC, Michael P. Chu, MD, Ismail Ismail, Jason Tay, MD FRCPC, Peter Duggan, MD FRCPC, Andrew Belch, Joanne D. Hewitt, NP, PhD, Linda M. Pilarski, PhD, Tatiana Nikitina, Christopher P. Venner
Journal: Blood
Blood (2017) 130 (Supplement 1): 1859.
https://doi.org/10.1182/blood.V130.Suppl_1.1859.1859
Published: 2017
Journal Articles

Efficacy of Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients with 1 to 3 Prior Lines of Therapy: Updated Analysis of Pollux

Saad Z Usmani, MD FACP, Meletios A Dimopoulos, Andrew Belch, Darrell White, MD, Lofti Benboubker, Gordon Cook, MD PhD, Merav Leiba, MD, James Morton, MBBS, BSc(MD, FRACP, FRCPA, P. Joy Ho, Kihyun Kim, Naoki Takezako, MD PhD, Nushmia Z Khokhar, Mary Guckert, Kaida Wu, MD PhD, Xiang Qin, Tineke Casneuf, Christopher Chiu, PhD, A. Kate Sasser, Jesús San-Miguel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1151.
https://doi.org/10.1182/blood.V128.22.1151.1151
Published: 2016
Journal Articles

Ex Vivo Modeling of Multiple Myeloma Provides Basis for Studying Treatment Combinations and Immunotherapy

Michael P. Chu, MD, Christopher P. Venner, MD, Irwindeep Sandhu, MD, Eva Baigorri, PhD, Jitra Kriangkum, PhD, Joanne D Hewitt, RN, BSN, NP, Andrew Belch, Linda M. Pilarski, PhD
Journal: Blood
Blood (2016) 128 (22): 2113.
https://doi.org/10.1182/blood.V128.22.2113.2113
Published: 2016
Journal Articles

Population Pharmacokinetic and Exposure-Response Analyses for Daratumumab in Combination Therapies for Patients with Multiple Myeloma Who Have Received 1 or More Prior Lines of Therapy

X. Steven Xu, Sam Liao, PhD, Meletios A Dimopoulos, Pieter Sonneveld, MD PhD, P. Joy Ho, Andrew Belch, MD, Merav Leiba, MD, Marcelo Capra, MD PhD, David Gomez, MD, Eva Medvedova, MD, Shinsuke Iida, MD PhD, Chang-Ki Min, MD, Ming Qi, Jordan Schecter, Nushmia Z. Khokhar, Xiaoyu Yan, Liping Zhang, Pamela L. Clemens
Journal: Blood
Blood (2016) 128 (22): 3340.
https://doi.org/10.1182/blood.V128.22.3340.3340
Published: 2016
Journal Articles

Final Analysis of Overall Survival from the First Trial

Thierry Facon, Meletios A Dimopoulos, Angela Dispenzieri, John V. Catalano, Andrew Belch, Michele Cavo, MD, Antonello Pinto, Katja Weisel, Heinz Ludwig, Nizar J. Bahlis, MD, Anne Banos, Mourad Tiab, Michel Delforge, Jamie D. Cavenagh, Catarina Geraldes, Je-Jung Lee, Christine Chen, Albert Oriol, Javier De La Rubia, Darrell White, Daniel Binder, Jin Lu, Kenneth C. Anderson, Philippe Moreau, Michel Attal, Jean-Paul Fermand, Herve Avet-Loiseau, Annette Ervin-Haynes, Guang Chen, Vanessa Houck, Cyrille Hulin, Lofti Benboubker
Journal: Blood
Blood (2016) 128 (22): 241.
https://doi.org/10.1182/blood.V128.22.241.241
Published: 2016
Journal Articles

Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma

Clinical Trials & Observations
Saad Z. Usmani, Brendan M. Weiss, Torben Plesner, Nizar J. Bahlis, Andrew Belch, Sagar Lonial, Henk M. Lokhorst, Peter M. Voorhees, Paul G. Richardson, Ajai Chari, A. Kate Sasser, Amy Axel, Huaibao Feng, Clarissa M. Uhlar, Jianping Wang, Imran Khan, Tahamtan Ahmadi, Hareth Nahi
Journal: Blood
Blood (2016) 128 (1): 37–44.
https://doi.org/10.1182/blood-2016-03-705210
Published: 2016
Includes: Supplemental data
Journal Articles

Pomalidomide-Containing Regimens (PCR) for the Treatment of Relapsed and Refractory Multiple Myeloma

Victor H Jimenez-Zepeda, MD, Christopher P. Venner, MD, Andrew Belch, Irwindeep Sandhu, MD, Tatiana Nikitina, Joanne D Hewitt, RN, BSN, NP, Peter Duggan, MD, Paola Neri, MD PhD, Fariborz Rashid-Kolvear, PhD, Nizar J Bahlis, MD
Journal: Blood
Blood (2015) 126 (23): 5384.
https://doi.org/10.1182/blood.V126.23.5384.5384
Published: 2015
Journal Articles

In Multiple Myeloma Progression Free and Overall Survival in the Relapsed Setting Remains Poor with Early Exposure to Novel Agents: Experience from a Real-World Cohort

Christopher P. Venner, MD, Nizar J Bahlis, MD, Paola Neri, MD PhD, Irwindeep Sandhu, MD, Peter Duggan, MD, Andrew Belch, MD, Joanne D Hewitt, RN, BSN, NP, Linda M. Pilarski, PhD, Tatiana Nikitina, Victor H Jimenez-Zepeda, MD
Journal: Blood
Blood (2015) 126 (23): 4261.
https://doi.org/10.1182/blood.V126.23.4261.4261
Published: 2015
Journal Articles

Skeletal Muscle Density Is Independently Prognostic of Outcomes in Newly Diagnosed Mantle Cell Lymphoma Patients: Post Hoc Analysis of LYM 3002

Michael P. Chu, MD, Andrew Belch, MD, Lixia Pei, PhD, Xue (Loya) Yang, PhD, Tadeusz Robak, MD PhD, Brendan Rooney, PhD, Andrew Cakana, MD, Helgi van de Velde, MD PhD, Michael B Sawyer, MD
Journal: Blood
Blood (2015) 126 (23): 1477.
https://doi.org/10.1182/blood.V126.23.1477.1477
Published: 2015
Journal Articles

A Frailty Scale Predicts Outcomes of Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone on the First Trial

Thierry Facon, Cyrille Hulin, Meletios A. Dimopoulos, Andrew Belch, Nathalie Meuleman, Mohamad Mohty, Wen-Ming Chen, Kihyun Kim, Elena Zamagni, Paula Rodriguez-Otero, MD PhD, William Renwick, Christian Rose, Adrian Tempescul, Antonio Palumbo, Shien Guo, Michael Sturniolo, Annette Ervin-Haynes, Jean-Paul Fermand
Journal: Blood
Blood (2015) 126 (23): 4239.
https://doi.org/10.1182/blood.V126.23.4239.4239
Published: 2015
Journal Articles

Impact of Cytogenetics on Outcomes of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone in the First (MM-020) Trial

Herve Avet-Loiseau, Cyrille Hulin, Lofti Benboubker, Meletios A. Dimopoulos, Andrew Belch, Donna Reece, John Catalano, Antonio Pinto, Heinz Ludwig, Nizar J Bahlis, Michele Cavo, Michel Attal, Philippe Moreau, Lugui Qiu, Richard LeBlanc, Rik Schots, S. Vincent Rajkumar, Jennifer Marek, Guang Chen, Wai Yiu, Annette Ervin-Haynes, Thierry Facon
Journal: Blood
Blood (2015) 126 (23): 730.
https://doi.org/10.1182/blood.V126.23.730.730
Published: 2015
Journal Articles

Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to Lenalidomide and Dexamethasone (LD) for the Treatment of Non-Transplant Eligible Multiple Myeloma

Victor H Jimenez-Zepeda, MD, Christopher P. Venner, MD, Andrew Belch, Irwindeep Sandhu, MD, Tatiana Nikitina, Joanne D Hewitt, RN, BSN, NP, Peter Duggan, MD, Paola Neri, MD PhD, Fariborz Rashid-Kolvear, PhD, Nizar J Bahlis, MD
Journal: Blood
Blood (2015) 126 (23): 1845.
https://doi.org/10.1182/blood.V126.23.1845.1845
Published: 2015
Journal Articles

Clinical Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma

Saad Usmani, Brendan Weiss, Nizar J Bahlis, MD, Andrew Belch, Sagar Lonial, MD, Henk Lokhorst, Peter M. Voorhees, MD, Paul G. Richardson, A Kate Sasser, Amy Axel, Huaibao Feng, Clarissa Uhlar, Jianping Wang, Imran Khan, Tahamtan Ahmadi, Hareth Nahi
Journal: Blood
Blood (2015) 126 (23): 29.
https://doi.org/10.1182/blood.V126.23.29.29
Published: 2015
Journal Articles

Eloquent-2 Update: A Phase 3, Randomized, Open-Label Study of Elotuzumab in Combination with Lenalidomide/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma - 3-Year Safety and Efficacy Follow-up

Meletios A. Dimopoulos, Sagar Lonial, MD, Darrell White, MD, Philippe Moreau, Antonio Palumbo, MD, Jesus San Miguel, MDPhD, Ofer Shpilberg, MD MPH, Kenneth C. Anderson, MD, Sebastian Grosicki, MD PhD, Ivan Spicka, MD PhD, Adam Walter-Croneck, Hila Magen-Nativ, Maria-Victoria Mateos, Andrew Belch, Donna Reece, Meral Beksac, MD, Eric Bleickhardt, Valerie Poulart, Jessica Katz, Anil K. Singhal, Paul G. Richardson
Journal: Blood
Blood (2015) 126 (23): 28.
https://doi.org/10.1182/blood.V126.23.28.28
Published: 2015
Journal Articles

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

Clinical Trials & Observations
Antonio Palumbo, Sara Bringhen, Maria-Victoria Mateos, Alessandra Larocca, Thierry Facon, Shaji K. Kumar, Massimo Offidani, Philip McCarthy, Andrea Evangelista, Sagar Lonial, Sonja Zweegman, Pellegrino Musto, Evangelos Terpos, Andrew Belch, Roman Hajek, Heinz Ludwig, A. Keith Stewart, Philippe Moreau, Kenneth Anderson, Hermann Einsele, Brian G. M. Durie, Meletios A. Dimopoulos, Ola Landgren, Jesus F. San Miguel, Paul Richardson, Pieter Sonneveld, S. Vincent Rajkumar
Journal: Blood
Blood (2015) 125 (13): 2068–2074.
https://doi.org/10.1182/blood-2014-12-615187
Published: 2015
Includes: Supplemental data